XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Accounting Policies [Abstract]      
Research and Development Expense $ 32,100 $ 61,419  
Deferred Revenue $ 140,000   $ 140,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 717,620,292 661,579,069  
Depreciation $ 5,465 $ 5,465